<p>The currently available vaccines against Covid-19 appear to be effective against the newly detected Omicron Covid variant, South Africa's health minister said.</p>.<p>The new variant, known as B.1.1.529, has been detected in small numbers in South Africa. The World Health Organization (WHO) on Friday assigned the Greek letter Omicron to the variant.</p>.<p>According to South African Health Minister Joe Phaahla, vaccines are still effective in preventing severe Covid from the variant, CNBC reported.</p>.<p>Phaahla added that the Omicron variant may be more transmissible due to its genetic composition.</p>.<p>Meanwhile, world's major manufacturers of Covid-19 vaccines said Friday that they are working to quickly investigate and adapt their shots to a new and highly mutated strain of the virus.</p>.<p>The WHO said the new strain may pose a higher risk of reinfection than past mutations of the virus.</p>.<p>Pfizer and BioNTech said they are investigating the new, heavily mutated variant, the report said.</p>.<p>The companies said they can adapt their mRNA vaccine within six weeks and start shipping batches within 100 days if an escape variant is identified.</p>.<p>Moderna, Johnson & Johnson and AstraZeneca have also stated that they are investigating and testing the new variant.</p>.<p>Moderna said it will test three booster candidates against Omicron, including a higher dosage level. The company will also develop a booster dose specific to the variant, it said in a statement.</p>.<p>The variant, which emerged in South Africa, has about 50 mutations, more than 30 of which are on the spike protein that allows the virus to bind to human cells.</p>.<p>While the spread of the new variant is still in its early stages, it is not yet clear how severe an infection would be to a vaccinated person.</p>.<p><strong>Check out DH's latest videos on Covid:</strong></p>
<p>The currently available vaccines against Covid-19 appear to be effective against the newly detected Omicron Covid variant, South Africa's health minister said.</p>.<p>The new variant, known as B.1.1.529, has been detected in small numbers in South Africa. The World Health Organization (WHO) on Friday assigned the Greek letter Omicron to the variant.</p>.<p>According to South African Health Minister Joe Phaahla, vaccines are still effective in preventing severe Covid from the variant, CNBC reported.</p>.<p>Phaahla added that the Omicron variant may be more transmissible due to its genetic composition.</p>.<p>Meanwhile, world's major manufacturers of Covid-19 vaccines said Friday that they are working to quickly investigate and adapt their shots to a new and highly mutated strain of the virus.</p>.<p>The WHO said the new strain may pose a higher risk of reinfection than past mutations of the virus.</p>.<p>Pfizer and BioNTech said they are investigating the new, heavily mutated variant, the report said.</p>.<p>The companies said they can adapt their mRNA vaccine within six weeks and start shipping batches within 100 days if an escape variant is identified.</p>.<p>Moderna, Johnson & Johnson and AstraZeneca have also stated that they are investigating and testing the new variant.</p>.<p>Moderna said it will test three booster candidates against Omicron, including a higher dosage level. The company will also develop a booster dose specific to the variant, it said in a statement.</p>.<p>The variant, which emerged in South Africa, has about 50 mutations, more than 30 of which are on the spike protein that allows the virus to bind to human cells.</p>.<p>While the spread of the new variant is still in its early stages, it is not yet clear how severe an infection would be to a vaccinated person.</p>.<p><strong>Check out DH's latest videos on Covid:</strong></p>